Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OABIthis companyOmniAb, Inc.	$5.36	-3.25×	0.79×	11.26×	-4.6×	-105.3%	-18.2%	-383.1%	-347.0%	-24.3%	-24.2%	-17.6%	0.08×	0.12×	0×	4.02×	0.0%	4	9.56	2	C
ABSIAbsci Corporation	$11.05	-4.15×	2.52×	170.48×	-4.48×	-99.6%	-319.4%	-4454.2%	-4113.7%	-60.8%	-63.6%	-19.7%	0.03×	0.14×	-596.74×	6.57×	0.0%	4	39.57	1	C-
MGNXMacroGenics, Inc.	$2.44	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
STROSutro Biopharma, Inc.	$10.50	-0.51×	-0.74×	0.96×	-0.38×	-557.0%	92.9%	-102.4%	-186.5%	144.3%	-98.5%	-182.0%	-0.12×	0.29×	-2.75×	2.01×	0.0%	3	-8.69	2	C
Peer median	—	-1.36×	1.83×	0.96×	-2.54×	-557.0%	71.1%	-102.4%	-186.5%	-60.8%	-63.6%	-81.6%	0.03×	0.14×	-8.56×	5.1×	0.0%	3	-4.43	1	—